Start the conversation
An update to Siri... Google Maps and Waze coming to CarPlay... a new photo system in iOS 12... and the debut of "Memoji," a feature that allows you to create your own emoji that mimics your particular facial expressions.
Those were just a few of the upgrades and new features announced Monday at the 11th annual Apple Inc. (Nasdaq: AAPL) Worldwide Developers Conference (WWDC).
CEO Tim Cook also noted the App Store, which is now 10 years old, is the largest app market in the world, with 500 million weekly visitors. It's brought in $100 billion for app developers.
It seems like the entire tech world is in San Jose, Calif., early this week for WWDC.
However, as worthy of attention as most of Apple's announcements are, the conversation here on the ground is all about "The Sweepstakes."
I'm talking about the race to be the first $1 trillion market-cap public company.
And this race is possible because of what we've been talking about since Day 1 here.
The road to wealth is paved by tech.
As far as I know, back in April 2015 I was the first tech analyst to predict that Apple would be the first U.S. company to reach a market cap of $1 trillion. That number now sits at $952.41 billion.
Two years after that, Warren Buffett followed my lead and said Apple would be the first company with a $1 trillion market cap. And this comes from the man whose Berkshire Hathaway Inc. (NYSE: BRK.A, B) was, at the time, even closer to that mark.
But you don't have to take my word for it. Even Wall Street is waking up to this very powerful and profitable fact.
Want to Make Money? Here's how to make over $100,000 starting with a small amount of money... rolling stocks over and over again. Click here for more about this proven investing method...
Back in December, Barron's predicted Apple will reach $1 trillion in market value in 2018. The rumblings for Apple to reach that value haven't stopped since.
Now, though, another "horse" has entered The Sweepstakes.
Morgan Stanley recently predicted that another company I have often recommended could hit a $1 trillion market cap in as little as a year.
Today, I'll tell you about Apple's big competition here.
I'll let you know who I think the winner will ultimately be.
And I'll show you how you can cash in on this race...
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.